| EP1636229 - A1 ADENOSINE RECEPTOR ANTOGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.05.2013 Database last updated on 21.03.2026 | Most recent event Tooltip | 31.05.2013 | Application deemed to be withdrawn | published on 03.07.2013 [2013/27] | Applicant(s) | For all designated states Endacea, Inc. P.O. Box 12076 Research Triangle Park, NC 27709-2076 / US | [2006/12] | Inventor(s) | 01 /
WILSON, Constance, N. 1112 Baslow Brook Court Raleigh, North Carolina 27614-8866 / US | 02 /
PARTRIDGE, John, J. 109 Muir Lane Chapel Hill, North Carolina 27514-1452 / US | [2006/12] | Representative(s) | Keen, Celia Mary, et al J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
| Former [2006/12] | Keen, Celia Mary, et al J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 04785932.7 | 04.06.2004 | [2006/12] | WO2004US18044 | Priority number, date | US20030476684P | 06.06.2003 Original published format: US 476684 P | [2006/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005009343 | Date: | 03.02.2005 | Language: | EN | [2005/05] | Type: | A2 Application without search report | No.: | EP1636229 | Date: | 22.03.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.02.2005 takes the place of the publication of the European patent application. | [2006/12] | Search report(s) | International search report - published on: | US | 12.05.2005 | (Supplementary) European search report - dispatched on: | EP | 30.06.2008 | Classification | IPC: | C07D473/04, C07D473/06, A61K31/522, A61P25/28, A61P25/24, A61P11/06, A61P11/00, A61P31/18, A61P37/08, A61P37/06, A61P25/16, A61P9/04 | [2006/12] | CPC: |
C07D473/04 (EP,US);
A61P1/00 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/14 (EP);
A61P13/00 (EP);
A61P13/12 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P25/36 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/18 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/12] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | A1-ADENOSINREZEPTORANTAGONISTEN | [2006/12] | English: | A1 ADENOSINE RECEPTOR ANTOGONISTS | [2006/12] | French: | ANTAGONISTES DU RECEPTEUR D'ADENOSINE A1 | [2006/12] | Entry into regional phase | 05.01.2006 | National basic fee paid | 05.01.2006 | Search fee paid | 05.01.2006 | Designation fee(s) paid | 05.01.2006 | Examination fee paid | Examination procedure | 05.01.2006 | Amendment by applicant (claims and/or description) | 05.01.2006 | Examination requested [2006/12] | 17.12.2010 | Despatch of a communication from the examining division (Time limit: M06) | 27.06.2011 | Reply to a communication from the examining division | 25.08.2011 | Despatch of a communication from the examining division (Time limit: M06) | 10.01.2012 | Reply to a communication from the examining division | 03.02.2012 | Despatch of a communication from the examining division (Time limit: M06) | 08.08.2012 | Reply to a communication from the examining division | 30.08.2012 | Despatch of a communication from the examining division (Time limit: M04) | 10.01.2013 | Application deemed to be withdrawn, date of legal effect [2013/27] | 15.02.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.12.2010 | Fees paid | Renewal fee | 05.01.2006 | Renewal fee patent year 03 | 14.06.2007 | Renewal fee patent year 04 | 28.03.2008 | Renewal fee patent year 05 | 16.06.2009 | Renewal fee patent year 06 | 11.06.2010 | Renewal fee patent year 07 | 13.06.2011 | Renewal fee patent year 08 | 14.06.2012 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E] WO2004110379 (ENDACEA INC et al.) [E] 1-13 * the whole document * | [E] WO2004074247 (ENDACEA INC et al.) [E] 1,13 * the whole document * | Examination | WO0177110 | US2003114469 | WO9822465 | US5338743 | BEAUGLEHOLE, A.R.; BAKER, S.P.; SCAMMELS, P.J.: "New Irreversible Adenosine A1 Antagonists Based on FSCPX", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, no. 12, 2002, pages 3179 - 3182, ISSN: 0960-894X |